Intal Side Effects

Generic name: cromolyn

Medically reviewed by Drugs.com. Last updated on Oct 19, 2023.

Note: This document contains side effect information about cromolyn. Some dosage forms listed on this page may not apply to the brand name Intal.

For Healthcare Professionals

Applies to cromolyn: compounding powder, inhalation aerosol with adapter, inhalation solution, nasal spray, oral capsule, oral solution.

General

Adverse reactions following use of this drug are rare; headache and diarrhea have been reported following oral use, while cough, nasal congestion, sneezing and wheezing have been reported with oral inhalation.^[Ref]

Hypersensitivity

Postmarketing reports: Anaphylaxis, laryngeal edema^[Ref]

Respiratory

Frequency not reported: Pharyngitis, dyspnea, cough, nasal congestion, sneezing, wheezing, nasal itching, nose bleed, nose burning

Postmarketing reports: Bronchospasm, pulmonary infiltrates with eosinophilia, hoarseness^[Ref]

Hematologic

Frequency not reported: Polycythemia, neutropenia, pancytopenia

Postmarketing reports: Anemia^[Ref]

Genitourinary

Postmarketing reports: Dysuria, urinary frequency^[Ref]

Dermatologic

Rare (less than 0.1%): Pruritus, rash

Frequency not reported: Urticaria/angioedema, erythema/burning, photosensitivity, purpura

Postmarketing reports: Photodermatitis, exfoliative dermatitis^[Ref]

Gastrointestinal

Rare (0.01% to 0.1%): Abdominal pain, nausea,

Frequency not reported: Diarrhea, constipation, dyspepsia, flatulence, glossitis, stomatitis, vomiting, dysphagia, oesophagospasm, unpleasant taste, stomachache, mild throat irritation

Postmarketing reports: Swollen parotid gland^[Ref]

Hepatic

Frequency not reported: Abnormal hepatic function test^[Ref]

Cardiovascular

Frequency not reported: Flushing, tachycardia, premature ventricular contractions, palpitations, chest pain

Postmarketing reports: Periarteritic vasculitis, pericarditis^[Ref]

Musculoskeletal

Rare (less than 0.1%): Myalgia

Frequency not reported: Arthralgia, stiffness/weakness of legs, lupus erythematosus syndrome

Postmarketing reports: Joint swelling and pain, polymyositis^[Ref]

Nervous system

Rare (0.01% to 0.1%): Headache

Frequency not reported: Dizziness, hypoesthesia, paresthesia, migraine, convulsions

Postmarketing reports: Peripheral neuritis^[Ref]

Psychiatric

Frequency not reported: Psychosis, anxiety, depression, hallucinations, behavior change, insomnia, nervousness^[Ref]

Other

Frequency not reported: Fatigue, malaise, tinnitus

Postmarketing reports: Vertigo^[Ref]

Ocular

Postmarketing reports: Lacrimation^[Ref]

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer